Su Jin Yim and colleagues argue that with the proposed definition of Alzheimer’s disease (AD) expanding in the most recent ...
The FDA has approved Evrysdi in tablet form for patients with spinal muscular atrophy aged 2 years and older who weigh more ...
A team led by Molly Shoichet, a professor in the department of chemical engineering and applied chemistry and the Institute ...
3don MSNOpinion
A federal judge on Tuesday temporarily paused three agencies from modifying or removing data from their websites and ordered ...
allAfrica.com on MSN5d
Kenya: 'My Cow, My Choice' - Kenyan Farmers Resist Livestock Vaccination CampaignA protest movement has emerged in Kenya against a government plan to provide free nationwide vaccinations for around 84 ...
Judith Yurcho and Dr. Edward Polashenski were recently honored as the 2024 Patients of the Year by the cardiac rehabilitation staff at the Health & Wellness Center at Hazleton. The cardiac ...
As detailed in our previous updates, the IRA’s Medicare Drug Price Negotiation Program (the Negotiation Program or Program), ...
The adjusted likelihood for an injurious fall in adults with COPD was elevated with a fall-risk increasing drug prescription, ...
Evrysdi is the only non-invasive disease-modifying SMA treatment and is approved in over 100 countries Evrysdi tablet can be stored at room temperature and offers the same demonstrated efficacy and sa ...
"The Evrysdi tablet combines established efficacy with convenience, providing an additional flexible option for SMA management." The approval of the Evrysdi tablet was based on the results of a ...
This is the year to be optimistic about Alzheimer’s disease says one of Australia’s leading dementia researchers.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback